JP2017514910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017514910A5 JP2017514910A5 JP2017510457A JP2017510457A JP2017514910A5 JP 2017514910 A5 JP2017514910 A5 JP 2017514910A5 JP 2017510457 A JP2017510457 A JP 2017510457A JP 2017510457 A JP2017510457 A JP 2017510457A JP 2017514910 A5 JP2017514910 A5 JP 2017514910A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- represented
- following formula
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 208000020084 Bone disease Diseases 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 206010017076 Fracture Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 208000029725 Metabolic bone disease Diseases 0.000 claims 1
- 206010049088 Osteopenia Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987739P | 2014-05-02 | 2014-05-02 | |
| US61/987,739 | 2014-05-02 | ||
| PCT/US2015/028917 WO2015168636A1 (en) | 2014-05-02 | 2015-05-01 | Bone-selective osteogenic oxysterol bisphosphonate analogs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017514910A JP2017514910A (ja) | 2017-06-08 |
| JP2017514910A5 true JP2017514910A5 (enExample) | 2018-06-14 |
| JP6530056B2 JP6530056B2 (ja) | 2019-06-12 |
Family
ID=54359404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510457A Expired - Fee Related JP6530056B2 (ja) | 2014-05-02 | 2015-05-01 | 骨選択的骨形成オキシステロールビスホスホネート類似体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10421773B2 (enExample) |
| EP (1) | EP3137480A4 (enExample) |
| JP (1) | JP6530056B2 (enExample) |
| CN (1) | CN106232612B (enExample) |
| AU (1) | AU2015252859B2 (enExample) |
| CA (1) | CA2945404A1 (enExample) |
| WO (1) | WO2015168636A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9670244B2 (en) | 2006-02-27 | 2017-06-06 | The Regents Of The University Of California | Oxysterol compounds and the hedgehog pathway |
| WO2013169399A1 (en) | 2012-05-07 | 2013-11-14 | The Regents Of The University Of California | Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis |
| US9683009B2 (en) | 2013-05-02 | 2017-06-20 | The Regents Of The University Of California | Bone-selective osteogenic oxysterol-bone targeting agents |
| KR20170101940A (ko) | 2014-12-09 | 2017-09-06 | 워쏘우 오르쏘페딕 인코포레이티드 | 스테롤 관련 화합물 및 방법 |
| US10632230B2 (en) | 2015-07-10 | 2020-04-28 | Warsaw Orthopedic, Inc. | Implants having a high drug load of an oxysterol and methods of use |
| US9987289B2 (en) | 2015-07-10 | 2018-06-05 | Warsaw Orthopedic, Inc. | Slow release oxysterols and methods of use |
| US9877836B2 (en) | 2015-07-10 | 2018-01-30 | Warsaw Orthopedic, Inc. | Compression resistant implants including an oxysterol and methods of use |
| US12171909B2 (en) | 2015-07-10 | 2024-12-24 | Warsaw Orthopedic, Inc. | Implants having a drug load of an oxysterol and methods of use |
| US9637514B1 (en) | 2015-10-26 | 2017-05-02 | MAX BioPharma, Inc. | Oxysterols and hedgehog signaling |
| US20170275330A1 (en) * | 2016-03-28 | 2017-09-28 | Warsaw Orthopedic, Inc. | Polymorphic forms of an oxysterol and methods of making them |
| US10688222B2 (en) | 2016-11-21 | 2020-06-23 | Warsaw Orthopedic, Inc. | Lyophilized moldable implants containing an oxysterol |
| US11384114B2 (en) | 2016-12-09 | 2022-07-12 | Warsaw Orthopedic, Inc. | Polymorphic forms of an oxysterol and methods of making them |
| US10294264B2 (en) | 2017-04-21 | 2019-05-21 | Warsaw Orthopedic, Inc. | Oxysterol-therapeutic agent derivative for bone healing |
| US10434106B2 (en) | 2017-05-19 | 2019-10-08 | Warsaw Orthopedic, Inc. | Oxysterol-statin compounds for bone growth |
| US11464888B2 (en) | 2017-06-12 | 2022-10-11 | Warsaw Orthopedic, Inc. | Moldable formulations containing an oxysterol in an acellular tissue matrix |
| WO2020019108A1 (en) * | 2018-07-23 | 2020-01-30 | Guangzhou Othrotx Co., Ltd. | Bisphosphonate drug conjugates |
| KR20220041152A (ko) * | 2019-07-24 | 2022-03-31 | 브라이엄 영 유니버시티 | 뼈-결합 화합물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| EP0496520A1 (en) | 1991-01-22 | 1992-07-29 | Merck & Co. Inc. | Novel bone acting agents |
| US5183815A (en) * | 1991-01-22 | 1993-02-02 | Merck & Co., Inc. | Bone acting agents |
| JP2746041B2 (ja) | 1992-02-14 | 1998-04-28 | 三菱化学株式会社 | 新規なステロイド誘導体 |
| JPH06329697A (ja) * | 1993-03-25 | 1994-11-29 | Kowa Co | 骨疾患治療剤 |
| DE102004032781A1 (de) | 2004-01-23 | 2005-08-11 | Mcs Micro Carrier Systems Gmbh | Bisphosphonsäurederivate |
| US9670244B2 (en) * | 2006-02-27 | 2017-06-06 | The Regents Of The University Of California | Oxysterol compounds and the hedgehog pathway |
| CA2679047C (en) * | 2007-02-23 | 2016-01-26 | University Of Louisville Research Foundation, Inc | Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| CN101951915A (zh) * | 2007-12-03 | 2011-01-19 | 加利福尼亚大学董事会 | 用于刺猬蛋白信号、骨诱导、抗脂肪形成和wnt信号的激活的氧固醇 |
| WO2012024584A2 (en) * | 2010-08-20 | 2012-02-23 | Fate Therapeutics, Inc. | Oxysterol compounds |
| EP2847205A4 (en) | 2012-05-07 | 2016-01-20 | Univ California | NOVEL OXYSTEROL ANALOGUE OXY149 FOR THE INDUCTION OF OSTEOGENESIS AND HEDGEHOG SIGNAL PATH AND THE INHIBITION OF ADIPOGENESIS |
| WO2013169399A1 (en) | 2012-05-07 | 2013-11-14 | The Regents Of The University Of California | Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis |
-
2015
- 2015-05-01 JP JP2017510457A patent/JP6530056B2/ja not_active Expired - Fee Related
- 2015-05-01 CA CA2945404A patent/CA2945404A1/en not_active Abandoned
- 2015-05-01 CN CN201580021530.7A patent/CN106232612B/zh not_active Expired - Fee Related
- 2015-05-01 US US15/302,154 patent/US10421773B2/en active Active
- 2015-05-01 EP EP15786795.3A patent/EP3137480A4/en not_active Withdrawn
- 2015-05-01 AU AU2015252859A patent/AU2015252859B2/en not_active Ceased
- 2015-05-01 WO PCT/US2015/028917 patent/WO2015168636A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015537020A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| EP4241772A3 (en) | Process for the preparation of compounds useful for treating spinal muscular atrophy | |
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| MX390302B (es) | Oxiesteroles y metodos de uso de los mismos | |
| EP4275748A3 (en) | Compositions and methods for treating cns disorders | |
| JP2015078230A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| MX2020010690A (es) | Oxiesteroles y metodos de uso de los mismos. | |
| JP2011518833A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| EP4275756A3 (en) | Bipyrazole derivatives as jak inhibitors | |
| JP2016540742A5 (enExample) | ||
| TN2017000075A1 (en) | Compounds and compositions as raf kinase inhibitors | |
| JP2018501215A5 (enExample) | ||
| EA201590735A1 (ru) | 2-фенил-5-гетероциклил-тетрагидро-2h-пиран-3-аминовые соединения для применения в лечении диабета и связанных с ним расстройств | |
| JP2017517565A5 (enExample) | ||
| JP2015516427A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| NZ705253A (en) | Derivatives of azaindazole or diazaindazole type for treating pain | |
| RU2018113718A (ru) | Новые соединения | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| JP2015516419A5 (enExample) |